What is a nursing consideration before administering magnesium sulfate intravenously?

Before administering magnesium sulfate intravenously, it is crucial to ensure that the patient's respirations are greater than 16 breaths per minute. This is important because magnesium sulfate can have a depressant effect on the respiratory system, particularly at higher serum levels. Monitoring respiratory status is essential to prevent complications such as respiratory depression, which can lead to inadequate oxygenation and pose significant risks to the patient.

By ensuring that respirations are within a safe range before administration, the healthcare provider can help mitigate risks and manage potential adverse effects effectively. This consideration is part of the broader assessment of the patient's status and response to treatment, particularly in the context of using magnesium sulfate for conditions like preterm labor or severe preeclampsia, where close monitoring of the patient is necessary.